Chinese Professional Carbetocin - GLP-1 (7-37) – JYMed
Chinese Professional Carbetocin - GLP-1 (7-37) – JYMed Detail:
Keywords
- Human GLP-1 (7-37)
- most affordable price
- CAS# 106612-94-6
Quick Details
- ProName: Human GLP-1 (7-37)
- CasNo:106612-94-6
- Molecular Formula: C151H228N40O47
- Appearance: white powder
- Application: 106612-94-6
- DeliveryTime: prompt shipment
- PackAge: according to customer’s requirements
- Port: Shenzhen
- ProductionCapacity: 2 Kilogram/Month
- Purity: 98%
- Storage: 2~8℃. protected from light
- Transportation: by air
- LimitNum: 1 Gram
Superiority
professional peptide manufacturer in china.
high quality with gmp grade
large scale with competitive price
our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.
Details
Molecular Formula：
C151H228N40O47
Relative Molecular Mass：
3355.71 g/mol
CAS-Number：
106612-94-6 (net)
Long-term Storage：
-20 ± 5°C
Synonyms：
Glucagon-Like Peptide 1 (7-37)
Sequence：
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg
-Gly-OH acetate salt
Fields of Application：
Diabetes II - not yet an approved application
Active Substance：
GLP-1 (7-37) is an insulinotropic peptide generated from the precursor peptide GLP-1 (1-37). After ingestion of a meal,
the truncated bioactive sequences GLP-1 (7-37) and GLP-1 (7-36) amide are secreted by the L cells of the intestinal
mucosa. Administration of GLP-1 (7-37) acetate augments glucose induced insulin secretion and simultaneously inhibits glucagon
secretion and gastric emptying.
Company Profile:
company name:Shenzhen JYMed Technology Co.,Ltd.
Year Established:2009
Capital: 89.5 Million RMB
Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin
Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
of ANDA peptide APIs and formulated products with CFDA and have over fourty patents approved.
Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.
Product detail pictures:
Related Product Guide:
FDA Approves 6-Month Formulation of Triptorelin for Prostate Cancer 3090D553-9492-4563-8681-AD288FA52ACE Group 2 34A8E98B-62ED-4216-98D6-E986304F4C2E | Lanreotide
Sartan Recalls Beg the Question: Is Compendial Impurity Testing Enough? | Pramlintide Acetate Gmp Exporter
We rely upon strategic thinking, constant modernisation in all segments, technological advances and of course upon our employees that directly participate inside our success for Chinese Professional Carbetocin - GLP-1 (7-37) – JYMed, The product will supply to all over the world, such as: UK, Slovenia, Japan, Our products are widely recognized and trusted by users and can meet continuously developing economic and social needs. We welcome new and old customers from all walks of life to contact us for future business relationships and achieving mutual success!
By Novia from Cologne - 2016.06.22 12:49
We feel easy to cooperate with this company, the supplier is very responsible, thanks.There will be more in-depth cooperation.
By Bella from Yemen - 2015.07.12 12:19
